Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Colrat

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|February 1, 2021
Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature reviewFlorian Colrat, Edward Thommes, Nathalie Largeron, et al.
Vaccine|January 29, 2021
Estimating public health and economic benefits along 10 years of Fluzone® High Dose in the United StatesPierre Net, Florian Colrat, Mafalda Nascimento Costa, et al.
European Journal of Haematology|February 6, 2026
Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell LymphomaCatherine Thieblemont, Florian Colrat, Rahma Sellami, et al.
World Journal of Urology|April 1, 2025
Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in FranceSylvie Negrier, Julia Bonastre, Florian Colrat, et al.
BMC Urology|May 12, 2025
Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohortAldéric Fraslin, Florian Colrat, Maryam Karimi, et al.
World Journal of Urology|March 17, 2023
Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR studyMorgan Roupret, Alice Brouquet, Florian Colrat, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|February 1, 2021
Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature reviewFlorian Colrat, Edward Thommes, Nathalie Largeron, et al.
Vaccine|January 29, 2021
Estimating public health and economic benefits along 10 years of Fluzone® High Dose in the United StatesPierre Net, Florian Colrat, Mafalda Nascimento Costa, et al.
European Journal of Haematology|February 6, 2026
Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell LymphomaCatherine Thieblemont, Florian Colrat, Rahma Sellami, et al.
World Journal of Urology|April 1, 2025
Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in FranceSylvie Negrier, Julia Bonastre, Florian Colrat, et al.
BMC Urology|May 12, 2025
Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohortAldéric Fraslin, Florian Colrat, Maryam Karimi, et al.
World Journal of Urology|March 17, 2023
Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR studyMorgan Roupret, Alice Brouquet, Florian Colrat, et al.
Pageof 1